Insmed (INSM) Interest Expenses (2011 - 2026)
Insmed (INSM) recorded quarterly Interest Expenses of $20.1 million in Q1 2026, down 2.51% quarter-over-quarter from $20.6 million in Q4 2025, and down 6.89% on a YoY basis from $21.6 million in Q1 2025.
Insmed (INSM) Interest Expenses (2011 - 2026) Analysis & Trends
Insmed's Interest Expenses history runs 16 years deep, the most recent figure standing at $20.1 million for Q1 2026.
- In Q1 2026, Interest Expenses fell 6.89% year-over-year to $20.1 million; the TTM figure through Mar 2026 stood at $82.3 million (down 3.67% YoY), while the FY2025 annual figure was $83.8 million, down 1.32% from the prior year.
- Interest Expenses was $20.1 million for Q1 2026 at Insmed, down from $20.6 million in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $21.6 million in Q1 2025 to a low of $3.3 million in Q1 2022.
- Historically, Interest Expenses has averaged $17.5 million across 5 years, with a median of $20.6 million in 2025.
- The sharpest annual moves came in 2022 and 2023: Interest Expenses slumped 70.18% in 2022, then jumped 514.21% in 2023.
- A 5-year view of Interest Expenses shows it stood at $16.4 million in 2022, then climbed by 26.38% to $20.8 million in 2023, then increased by 3.69% to $21.6 million in 2024, then declined by 4.41% to $20.6 million in 2025, then dropped by 2.51% to $20.1 million in 2026.
- The last three Interest Expenses figures came in at $20.1 million (Q1 2026), $20.6 million (Q4 2025), and $20.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | -5.50 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | 61,000.00 |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | -332,000.00 |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | -2,753.00 |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -5.58 Mn |
| 10 | Insmed | 19.79 Bn | 18.57 Bn | 258.54 Mn | 20.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20.08 Mn |
| Mar 31, 2026 | 20.08 Mn |
| Dec 31, 2025 | 20.60 Mn |
| Dec 31, 2025 | 20.60 Mn |
| Sep 30, 2025 | 20.38 Mn |
| Sep 30, 2025 | 20.38 Mn |
| Jun 30, 2025 | 21.25 Mn |
| Jun 30, 2025 | 21.25 Mn |
| Mar 31, 2025 | 21.57 Mn |
| Mar 31, 2025 | 21.57 Mn |
| Dec 31, 2024 | 21.55 Mn |
| Dec 31, 2024 | 21.55 Mn |
| Sep 30, 2024 | 21.05 Mn |
| Sep 30, 2024 | 21.05 Mn |
| Jun 30, 2024 | 21.27 Mn |
| Jun 30, 2024 | 21.27 Mn |
| Mar 31, 2024 | 21.04 Mn |
| Mar 31, 2024 | 21.04 Mn |
| Dec 31, 2023 | 20.78 Mn |
| Dec 31, 2023 | 20.78 Mn |